David Raben, Chief Medical Officer at Bicara Therapeutics Inc. (BCAX), sold 22,000 shares at $18.45 ($406K) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($406k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-03-05 | $607K | — | Filing → |
| BCAX | SELL | 2025-11-25 | $292K | — | Filing → |